Daniel Casserly is named as a lobbyist on federal disclosure filings for 1 client through Novartis. The most recent filing naming them posted in July 2020. Issues reported include Health Issues, Taxation/Internal Revenue Code, Copyright/Patent/Trademark and Medicare/Medicaid.
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| NOVARTIS | NOVARTIS | Q2 2020 | Medicare/Medicaid, Budget/Appropriations, Copyright/Patent/Trademark |
| Year | Clients | Registrants |
|---|---|---|
| 2020 | 1 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Daniel Casserly. See the Capitol Clarity rankings and method.